News
Videos
Conferences
Events
Resources
Subscribe

|Videos|June 15, 2022

Treatment Options for Patients with Renal Cell Carcinoma (RCC)

Author(s)Thomas Hutson, DO, PharmD

An overview of the treatment options available for patients with renal cell carcinoma (RCC).

Episodes in this series

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)

EP. 2 Clinical Implications of the TIVO-3 Trial

EP. 2 Clinical Implications of the TIVO-3 Trial

EP. 3 Tivozanib: Adverse Event Profile and How Toxicities are Managed

EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)

EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)

Newsletter

Stay up to date on cancer updates, research and education

Related Content

The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration

September 20th 2024

Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors

September 20th 2024

Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs

September 13th 2024

CLL Treatment and Quality of Life: Patient Empowerment and Shared Decision-making

September 13th 2024

LL Treatment Roadmap: Navigating First-Line Options With Your Doctor

September 6th 2024

Trending on CURE

A Survivor's 30-Year Wait for Lymphedema Relief Ends with Hackensack's New Supermicrosurgery Robotic Procedure

Gastrointestinal Stromal Tumor: Comprehensive Patient Guide

FDA Grants Orphan Drug Designation to MNV-201 for Myelodysplastic Syndrome

What Breast Cancer Awareness Means to Me as a 23-Year Survivor

Jakafi Trial Shows Benefits for Patients with Myelofibrosis and Anemia

© 2025 MJH Life Sciences^®

All rights reserved.